S.Kahraman 1,4, M.Bahçe 2,H.Şamlı 3, N.İmirzalıoğlu 2, K.Yakısn 1, G.Cengiz 1 and E.Dönmez 1
|
|
- Katrina Colleen Johnston
- 6 years ago
- Views:
Transcription
1 Human Reproduction vol.15 no.9 pp , 2000 Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation failure S.Kahraman 1,4, M.Bahçe 2,H.Şamlı 3, N.İmirzalıoğlu 2, K.Yakısn 1, G.Cengiz 1 and E.Dönmez 1 1 Sevgi Hospital, Assisted Reproductive Technologies and Reproductive Endocrinology Unit, 2 G.A.T.A., Genetic Division and 3 Sevgi Hospital, Genetic Division, Ankara, Turkey 4 To whom correspondence should be addressed at: İstanbul Memorial Hospital, Reproductive Endocrinology and ART Unit, Piyalepasa Bulvar1, 80270, Okmeydan1 Şişli İstanbul, Turkey. semrakahraman@hotmail.com Preimplantation genetic diagnosis (PGD) and subsequent embryo development was evaluated in 72 couples presenting at our centre for intracytoplasmic sperm injection (ICSI) due to severe male factor. The embryo biopsies were performed in Ca 2 /Mg 2 -free medium. These patients were further divided into those with advanced maternal age (AMA, n 49) and those with recurrent implantation failure (RIF, n 23). Fluorescence in-situ hybridization (FISH) was carried out on 329 blastomeres (91.3%) with probes for the X, Y, 13, 18 and 21 chromosomes. The chromosomal abnormality rate was 41.3% with no significant difference between the AMA and RIF groups. Aneuploidy accounted for the majority (72.8%) of chromosomal abnormalities. Out of 329 embryos, 84.2% had cleaved after 24 h and 15.1% had arrested. Embryos were transferred in 70 patients and 22 pregnancies were achieved (31.4% with an ongoing pregnancy rate of 28.5%). There were no significant differences between the pregnancy rates of the AMA and RIF groups (32.5 and 30% respectively). Therefore PGD should be offered to patients with AMA and RIF. Furthermore, the use of Ca 2 /Mg 2 -free medium during the blastomere biopsy facilitates the procedure, while further embryo cleavage, ongoing pregnancies and healthy births are possible. Key words: aneuploidy/ca 2 /Mg 2 -free medium/chromosomes X, Y, 13, 18, 21/FISH/preimplantation genetic diagnosis Introduction Preimplantation genetic diagnosis (PGD) allows for the selection of chromosomally normal embryos for transfer after IVF or intracytoplasmic sperm injection (ICSI) in patients with advanced maternal age (AMA) carrying a risk for aneuploidy. Aneuploidy may be a major contributing factor of implantation failure in women of AMA undergoing assisted reproduction treatment. Therefore, the selection of normal embryos could increase the rate of pregnancy and healthy offspring. PGD offers an alternative to the prenatal diagnosis in couples with a risk of transmitting inherited diseases. Furthermore, recurrent implantation failure (RIF) occurs in some young patients even when good quality embryos are transferred. Chromosomal evaluation of the embryos in these patients could provide further insights into the reasons for RIF. PGD is still being evaluated by several centres for patients with RIF and recurrent abortion if aneuploidy is present. It has been reported that embryo biopsy is easier to perform in the absence of Ca 2 /Mg 2 ions (Grifo et al., 1990; Santalo et al., 1996). No detrimental effects on the viability of biopsied mouse embryos were observed during the limited time of exposure to Ca 2 /Mg 2 -free medium compared to the control group. However, it has been reported that a prolonged exposure to Ca 2 /Mg 2 -free medium resulted in impaired embryonic development (Ducibella and Anderson, 1976; Reeve, 1981). The possible toxic effects on embryo and embryonic development to the blastocyst stage were studied when Ca 2 /Mg 2 - free medium was used in humans (Dumoulin et al., 1998). In this study, human embryos that were left over after in-vitro fertilization (IVF) and that were considered unsuitable for freezing were used to assess the effect of Ca 2 /Mg 2 -free medium on human embryos, further embryo development and pregnancies after embryo biopsy for PGD. To our knowledge, this is the first study reporting further human embryo development, ongoing pregnancies and healthy births with Ca 2 / Mg 2 -free medium for embryo biopsy. Material and methods This study was undertaken at Sevgi Hospital Embryology and Genetic Laboratory between December 1998 and June Third day embryos were biopsied in 72 patients for chromosomal evaluation. AMA (49 patients) and RIF groups with more than two cycles were included. From these two groups eight patients had centrally located granular oocytes (Figure 1) in their present and previous cycles and six male partners had megalo-pin head spermatozoa globozoospermic forms and round spermatids in their ejaculates (Figure 2). Patients signed a consent form before PGD consenting to the use of their embryos for blastomere biopsy and in case of pregnancy, amniocentesis. This study has been approved by the local ethical committee of Sevgi Hospital. An embryo biopsy was performed at h after ICSI and only embryos with more than seven or eight blastomeres were selected for biopsy. Pedigree analysis, family history and appropriateness of cases for PGD were evaluated. Patients were counselled regarding the advantageous of aneuploidy screening. Furthermore, couples were counselled regarding possible increased risk of sex chromosomal abnormalities in offspring and the need for follow-up prenatal testing. Males were karyotyped and counselled for the possibility of gonadal European Society of Human Reproduction and Embryology 2003
2 S.Kahraman et al. mosaicism or Y chromosome deletion/insertion. From February 1999, Y chromosome deletions are performed in our Molecular Genetic Laboratory. Figure 1. Centrally located granular oocytes. Excessive central granular structures (big arrows). Figure 2. A megalohead spermatozoon (MHS) (big arrow) together with pin-head spermatozoon (PHS) (small arrow) and round spermatid (RS). Figure 3. Trisomy 13. A blastomere FISH analysis with an extra signal of chromosome Embryo biopsy A stimulation protocol previously described (Kahraman et al., 1999) was employed. In 72 cases with 72 cycles an ICSI procedure was performed due to severe male infertility with AMA and RIF. Embryos were placed in HEPES-buffered medium without Ca 2 /Mg 2 ions (EB TM -10 Medium, Scandinavian IVF Science, Gothenburg, Sweden) before the biopsy procedure. Embryos were incubated for 5 25 min with EB TM -10 medium according to the degree of compaction between blastomeres. Embryos with compacted blastomeres on the third day were exposed to between 15 and 25 min to an EB TM -10 medium. Granulation of blastomeres was observed in these embryos exposing a relatively longer duration. Each Petri dish contained 10 ml of EB TM -10 medium covered with sterile equilibrated mineral oil. The first droplet was prepared for biopsy procedure and the second one was to replace the biopsied blastomere(s) in the same Petri dish. Three-dimensional partial zona dissection in the shape of crosshatching or V-shape was performed to facilitate the biopsy procedure as was originally introduced by Verlinsky s group (Cieslak et al., 1999). V-shaped assisted hatching was performed in most of the embryos to create a triangular flap opening with a diameter of mm to allow the replacement of the blastomere biopsy pipette. In 67.2% of the embryos, blastomeres were biopsied by pressing the zona pellucida with a biopsy pipette to make the blastomere protrude from the zona opening. In the remaining embryos (32.8%), blastomeres were biopsied by entering the opening of the zona pellucida with the biopsy pipette. The biopsy procedure was executed h after insemination for embryos obtained by ICSI. Only embryos with seven or more blastomeres were selected for biopsy. Embryos with a poor morphology with uneven blastomeres and a fragmentation rate of 30% were excluded. After the biopsy was done on third day embryos without compaction, the embryos were replaced in the EB TM -10 medium for approximately between 5 and 15 min. When compaction with tight junction between blastomeres was observed, min of exposure to EB TM 10 medium was preferred. Each biopsy procedure was performed by the same operator and was observed by a second person by means of a monitor, connected to a video camera mounted on a microscope. The duration of the biopsy procedure was noted from the beginning (from fixing embryos with a holding pipette to replacing single biopsied blastomeres in a second EB TM -10 droplet) to the end. The embryo to be biopsied was placed in a Petri dish in Ca 2 /Mg 2 -free medium containing 3 mg/ml HSA and 100 IU/ml Pc-6 EB TM -10 after equilibration at 37 C and 5% CO 2. The number of blastomeres in the beginning of the procedure, biopsied blastomeres, nucleus, multinucleated blastomeres, damaged blastomeres in the embryo or damaged biopsied blastomeres were recorded. The type of biopsy protrusion and subsequent development of embryos were observed for 24 h more to follow their developmental capacity. Any signs of cell or embryo damage were recorded. Biopsied embryos were cultured overnight (24 h more) both to observe their further development and to allow for a sufficient period for FISH procedure. Statistical analysis was performed using a Student s t-test or χ 2 test, where appropriate. Fluorescence in-situ hybridization (FISH) The isolated blastomeres were analysed with a previously described protocol (Munné et al., 1993) except for the hybridization time,
3 Survey of PGD in patients with AMA and RIF Table I. Results of chromosomal analysis (n 329) Results Embryos analysed n (%) Normal Abnormal Aneuploidy Trisomy Monosomy Double monosomy Double trisomy Trisomy monosomy Complex aneuploidy Polyploidy Haploidy which was 3 h. A Nikon E-600 microscope with filters recommended by Vysis for the probe mixture was used. The scoring criteria described previously (Munné and Weier, 1996) were followed and minor hybridization spots with low fluorescence intensity were not scored. For the multicolour FISH analysis, five DNA probes were used for the simultaneous detection of chromosomes X, Y, 13, 18 and 21 (Figure 3). Embryos were classified as complex abnormal when two or more chromosomes had an abnormal count but were not completely polyploid or haploid. The blastomeres of abnormal embryos not being transferred were fixed and evaluated by FISH procedure to confirm the diagnosis. Results In a total of 72 patients, PGD was performed for AMA in 49 (68%) patients and RIF in 23 (32%) patients. The mean ages of AMA and RIF patients were and respectively (P 0.05). In all, 360 embryos were selected for biopsy. A successful FISH analysis was carried out in 329 out of 360 blastomeres (91.3%); the rates of normal and abnormal chromosomal evaluation of embryos were 58.7 and 41.3% respectively. In 99 (72.8%) of abnormal embryos, aneuploidy was diagnosed. In seven (5.1%) of the embryos haploidy, in 13 (9.6%) polyploidy and in 17 (12.5%) complex aneuploidy were diagnosed. Out of 329 embryos analysed, 58.7% were found to be normal while 41.3% had chromosomal abnormality. The majority of the abnormal embryos were found to have aneuploidy (72.8%). Polyploidy, complex aneuploidy and haploidy were found to be 9.6, 12.5 and 5.1% respectively. Monosomy was diagnosed in 40.8% of the aneuploid embryos; 47.5% trisomy, 3.9% double monosomy, 3.9% double trisomy, 3.9% trisomy monosomy were observed respectively. The most significant chromosomal abnormality was observed in chromosome 18 (P 0.05) (35.3%) in the aneuploid embryo group, with chromosome 21 second at 27.1%, and chromosome 13 third at 22.4%. Table I shows results of chromosomal analysis. In the AMA group, the rates of chromosomally abnormal and normal embryos were 40.4 and 59.6% respectively. The majority of the abnormal embryos had aneuploidy (76.1%). Polyploidy, complex aneuploidy and haploidy were found in 10.3, 9.1 and 4.5% of embryos respectively. The rates of chromosomally abnormal and normal embryos in the RIF group were 43.2 and 56.8%. The majority of abnormal Table II. Distribution of the further development of embryos and duration of biopsy n 3 min 3 min Mean SD Mean SD Normal cleaved embryos Slow developed embryos Arrested embryos There were no significant differences between the two durations of biopsy groups. Table III. A comparison of characteristics of assisted reproduction cycles in patients with advanced maternal age (AMA) and repeated implantation failure (RIF) AMA RIF P-value* n 49 n 23 mean SD mean SD Age No. of oocytes obtained Fertilization with 2 PN (69) (75) 0.05 Cleaved embryos (91) (81) NS Biopsied embryos (67) (63) NS Abnormal embryos (39) (46) NS Transferred embryos (57) (53) NS *t-test. NS not significant. Values in parentheses are percentages. embryos had aneuploidy (66.7%). Polyploidy, haploidy and complex aneuploidy were found in 8.3, 6.2 and 18.8% of embryos respectively. The mean duration of the biopsy procedure from the beginning of assisted hatching to the replacing blastomere(s) in another droplet containing Ca 2 /Mg 2 -free medium was minutes per biopsy procedure. Table II shows the further development of embryos exposed for 3 min (1 3 min) and 3 min (3 8 minutes) to EB TM -10 medium during the biopsy procedure. In 32.8% of embryos a blastomere biopsy was performed by pressing zona pellucida with a biopsy pipette to make the blastomere protrude from the zona opening whilst in 67.2% of embryos, biopsy pipette was inserted into the embryo to remove one or two blastomeres. Table III represents a comparison of characterictics of assisted reproduction cycles in patients with AMA and RIF. No statistical significant difference was observed between the rate of cleaved, biopsied, abnormal and transferred embryos (P 0.05). The fertilization rate was found to be higher in the RIF group probably due to the higher number of oocytes obtained (P 0.05). Although the number of embryos (n 21) evaluated chromosomally was low in cases with megalo spermic samples (n 6), high rates of aneuploidy (62.5%) and polyploidy (31.3%) were observed, probably due to a high incidence of diploidy in megalo head spermatozoa. A high aneuploidy rate was found (76%), while 24% of embryos were chromosomally normal in this group. 2005
4 S.Kahraman et al. Eight patients had centrally located excessive granular oocytes (CLGO) in their previous and present cycles. As very low implantation and ongoing pregnancy rates (4.7%, unpublished data) were achieved. PGD was performed to evaluate the chromosomal complement of this group. Thirtynine percent of embryos were found to be chromosomally abnormal in the CLGO group, while 61% of embryos were found to be normal. The majority of abnormal embryos had aneuploidy (56.2%) in the same group. The rate of normally cleaving embryos on the fourth day was 84.2 and 15.8% of the embryos arrested. Out of 84.2% normally cleaved embryos, 18.1% of them exhibited a slow cleavage (an increase of less than two blastomeres in 24 h). Of the 72 cases, two patients had no transfer due to the lack of chromosomally normal embryos. Out of 110 chromosomally normal embryos transferred, a total of 22 pregnancies were achieved in 70 patients (31.4%). One pregnancy ended with a spontaneous abortion at 8 weeks and one ended with a blighted ovum at 6 weeks. The cytogenetic evaluation of both patients pregnancy material revealed 46, XY; 46, XX chromosomal complement, confirming the results of PGD. The rate of ongoing pregnancy was found to be 28.5% in total, a 25.5% ongoing pregnancy rate was achieved in AMA and 30.4% in RIF group respectively (P 0.05). Ten healthy births have been achieved; other pregnancies are continuing into the third trimester. Discussion Many factors have been attributed to the low success rate of assisted reproduction in women of advanced maternal age. These factors can either be endometrial or oocyte related. Defective hormonal milieu, poor uterine flow and inadequate endometrial proliferation cause reduced endometrial receptivity and thus implantation failure. Alternatively, reduced embryo quality, ageing of oocytes and chromosomally imbalance may explain a low success rate in AMA. This explanation is supported by the fact that, if oocytes from younger women are donated to the older women, successful pregnancies can be achieved (Navot et al., 1994). PGD for women aged between 36 and 45 years undergoing assisted reproduction were evaluated by using multiprobe FISH for chromosomes X, Y, 18,13 and 21. It has been demonstrated that additional chromosomes, in particular chromosome 16, were most frequently involved in aneuploid karyotypes (Bahce et al., 1999). Thus it might be beneficial to analyse a larger set of chromosomes to improve pregnancy rates in these patients. The minimum and maximum exposure of embryos to the EB medium during biopsy was between 5 and 25 min depending on the severity of compaction between blastomeres. The subsequent embryo development was not affected when the cell number was seven or more. More compacted embryos were exposed for 10 min. The minimum and maximum duration of the biopsy procedure from the beginning of the assisted hatching to the end of the biopsy was 1 min 20 s and 8 min respectively. The use of Ca 2 /Mg 2 -free medium for biopsy on human embryos to seven or more cells allows an easy biopsy with a low rate of cell lysis as well as a shorter 2006 time needed to perform the biopsy. A shorter biopsy procedure was carried out with the use of Ca 2 /Mg 2 -free medium on human embryos to remove blastomeres with a low rate cell lysis (Dumoulin, 1998). However, the possible toxic effects on embryo and human blastocyst were not studied on embryos that would be transferred. To our knowledge, this is the first study to evaluate the effect of Ca 2 /Mg 2 -free medium on the development of human embryos and pregnancies. If the majority of embryos to be biopsied were found to have five to six cells on the morning of the third day, they were checked 4 5 h later. Unfortunately, no pregnancy was achieved by transferring these slow growing embryos. This may indicate a poor implantation due to chromosomal, physiological or unknown reasons. The parameter used in our study was to assess further embryo viability. Slow growing embryos, arrested embryos or normally cleaving embryos were evaluated. Only 15% of embryos were found to be arrested 24 h later. After a further 2 3 day observation of arrested embryos, very few reached the blastocyst stage. If an increase of fewer than two blastomeres was observed, these embryos were recorded as slow growing embryos (17%). There was no statistical difference between the cleavage rates and biopsy duration was less or more than 3 min (P 0.05). The time needed for removal was noted together with the rate of intact cells. Biopsy time was calculated from the embryo fixation with a holding pipette to placing the biopsied blastomere(s) to another droplet. In fact, the length of fixation of embryos with opened zona to the placing EB TM -10 medium was almost always 1 min. Based on embryo morphological evaluation, 360 embryos were selected for blastomere biopsy. The links between the numbers of cumulus oocyte complexes (COC) and biopsied embryos and between the numbers of COC and unaffected embryos were found to be highly suggestive (P 0.05) (Vandervorst, 1998). It has been claimed that it is justifiable to cancel PGD cycles in which it is expected that fewer than six COC will be retrieved. The mean fertilization rates with 2PN were and in AMA and RIF groups respectively in our study (P 0.05). The fertilization rate was found to be higher in RIF group. This may be due to the number of oocytes obtained. The mean numbers of chromosomally abnormal embryos were found to be similar in the AMA and RIF groups ( versus ) (P 0.05). Embryos with only grade I and II were used for biopsy. Poor embryo morphology and a low rate of cleavage are associated with a high incidence of chromosome disorder when compared with normally developing embryos. In our experience with slow developing embryos where biopsies were performed on the third day, no pregnancy was achieved. Six patients had megalohead and pin-head sperm samples in their ejaculates. A high number of sperm heads without tails and abundant round spermatid forms were commonly observed. Round-headed spermatozoa were seldom accompanied by these severely abnormal spermatozoa. Low fertilization and pregnancy rates were achieved (43.2 and 9.1%) with these severely defective forms in our recent study (Kahraman et al., 1999). Low fertilization and pregnancy rates might be due to a high incidence of chromosomal abnormalities. PGD was
5 Survey of PGD in patients with AMA and RIF performed to evaluate a chromosomal complement in this group. A high aneuploidy rate was found (76%), while 24% of embryos had normal chromosomes. Therefore, couples should be counselled about low rates of fertilization and pregnancy with ICSI when only pin-head megalohead forms are present in the ejaculate. Pregnancy rates were found to be similar in both AMA and RIF groups. PGD also resulted in similar pregnancy rates for both groups. PGD also resulted in similar findings for both groups. In patients with RIF, a 30.4% ongoing pregnancy rate was encouraging. In AMA group patients aged between 36 45, a 25.5% pregnancy rate was achieved. Only one pregnancy resulted in a blighted ovum in AMA group presenting a low (7.6%) biochemical abortion rate. Ten healthy babies were born and the other pregnancies are continuing into the third trimester. Thus PGD may be offered to the patients with repeated implantation failure and to women with advanced maternal age. Ca 2 /Mg 2 -free medium allows for an easier biopsy procedure during PGD with less chance of damaging the embryo. At the same time, it does not result in any loss developmental potential to the morula or even blastocyst stage. A lower rate of cell lysis and a shorter time are needed for this procedure. The use of calcium and magnesium free media is facilitates biopsy of cleavage stage embryos with seven to eight cells or morula stages. References Bahce, M., Cohen, J. and Munné, S. (1999) Preimplantation genetic diagnosis of aneuploidy: were we looking et the wrong chromosomes? J. Assist. Reprod. Genet., 16, Cieslak, J., Ivakhnenko, V., Wolf, G. et al. (1999) Three-dimensional partial zona dissection for preimplantation genetic diagnosis and assisted hatching. Fertil. Steril., 71, Ducibella, T. and Anderson, E. (1979) The effect of calcium deficiency on the formation of the zona occludens and blastocoel in the mouse embryo. Dev. Biol., 73, Dumoulin, J.C.M., Bras, M., Coonen, E. et al. (1998) Effect of Ca 2 /Mg 2 - free medium on the biopsy procedure for preimplantation genetic diagnosis on further development of human embryos. Hum. Reprod., 13, Grifo, J.A., Boyle, A., Ficher, E. et al. (1990) Preembryo biopsy and analysis of blastomeres, by in situ hybridization. Am. J. Obstet. Gynecol., 163, Kahraman, S., Akarsu, C., Cengiz, G. et al. (1999) Fertility of ejaculated and testicular megalohead spermatozoa with intracytoplasmic sperm injection. Hum. Reprod., 14, Munné, S. and Weier, H.U.G. (1996) Simultaneous enumeration of chromosomes 13,18,21, X and Y in interphase cells for preimplantation genetic diagnosis. Cytogenet. Cell. Genet., 75, Munné, S., Grifo, J., Cohen, J. et al. (1993) Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum. Reprod., 8, Navot, D., Drews, M.R., Bergh, P.A. et al. (1994) Age related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation. Fertil. Steril., 61, Reeve, W.J.D. (1981) The distribution of ingested horsea dish peroxidanse in the 16-cell mouse embryo. J. Embryol. Exp. Morphol., 66, Santalo, J., Grossman, M. and Egozcue, J. (1996) Does Ca 2 /Mg 2 -free medium have an effect on the survival of the preimplantation mouse embryo after biopsy? Hum. Reprod. Update, 2, Vandervorst, M., Liebaers, I., Sermon, K. et al. (1998) Succesful preimplantation genetic diagnosis is related to the number of available cumulus oocyte complexes. Hum. Reprod., 13, Received on October 15, 1999; accepted on June 5,
Preimplantation genetic diagnosis: polar body and embryo biopsy
Human Reproduction, Vol. 15, (Suppl. 4), pp. 69-75, 2000 Preimplantation genetic diagnosis: polar body and embryo biopsy Luca Gianaroli SISMER, Via Mazzini 12, 40138 Bologna, Italy Scientific Director
More informationIncidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients
Incidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients M. C. MAGLI,1 L. GIANAROLI,1,3 S. MUNNE,2 and A. P. FERRARETTI1 Submitted: December 29,
More informationIndications for chromosome screening Dagan Wells, PhD, FRCPath dagan.wells@obs-gyn.ox.ac.ukgyn.ox.ac.uk Chromosome imbalance (aneuploidy) Uncontroversial data The incidence of aneuploidy Aneuploidy is
More informationArticles Impact of parental gonosomal mosaicism detected in peripheral blood on preimplantation embryos
RBMOnline - Vol 5. No 3. 306 312 Reproductive BioMedicine Online; www.rbmonline.com/article/699 on web 12 September Articles Impact of parental gonosomal mosaicism detected in peripheral blood on preimplantation
More informationFertility of ejaculated and testicular megalohead spermatozoa with intracytoplasmic sperm injection
Human Reproduction vol.14 no.3 pp.726 730, 1999 Fertility of ejaculated and testicular megalohead spermatozoa with intracytoplasmic sperm injection S.Kahraman 1,4, C.Akarsu 1, G.Cengiz 1, K.Dirican 1,
More informationEffect of chromosomal translocations on the development of preimplantation human embryos in vitro
FERTILITY AND STERILITY VOL. 74, NO. 4, OCTOBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A.,2 Effect of chromosomal
More informationIVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW
IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation
More informationPreimplantation Genetic Testing
Protocol Preimplantation Genetic Testing (40205) Medical Benefit Effective Date: 01/01/14 Next Review Date: 09/14 Preauthorization No Review Dates: 09/11, 09/12, 09/13 The following Protocol contains medical
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationLuca Gianaroli, M.D.,* M. Cristina Magli, M.Sc.,* Anna P. Ferraretti, Ph.D.,* and Santiago Munné, Ph.D.
FERTILITY AND STERILITY VOL. 72, NO. 5, NOVEMBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Preimplantation diagnosis
More informationChromosomal Aneuploidy
The Many Advantages of Trophectoderm Biopsy Compared to Day 3 Biopsy for Pre- Implantation Genetic Screening (PGS) Mandy Katz-Jaffe, PhD Chromosomal Aneuploidy Trisomy 21 Fetus Aneuploidy is the most common
More informationINSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018
INSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018 IVF-THE ULTIMATE GOAL FERTILISATION EMBRYO CLEAVAGE AND DEVELOPMENT POSITIVE HCG POSITIVE
More informationAbstract. Introduction. RBMOnline - Vol 11. No Reproductive BioMedicine Online; on web 11 August 2005
RBMOnline - Vol 11. No 4. 2005 497 506 Reproductive BioMedicine Online; www.rbmonline.com/article/1712 on web 11 August 2005 Article FISH screening of aneuploidies in preimplantation embryos to improve
More informationAbstract. Introduction. RBMOnline - Vol 10. No Reproductive BioMedicine Online; on web 19 January 2005
RBMOnline - Vol 10. No 3. 2005 381-388 Reproductive BioMedicine Online; www.rbmonline.com/article/1593 on web 19 January 2005 Article Preimplantation genetic diagnosis for aneuploidy screening in repeated
More informationUnderstanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre
Understanding eggs, sperm and embryos Marta Jansa Perez Wolfson Fertility Centre What does embryology involve? Aims of the embryology laboratory Creation of a large number of embryos and supporting their
More informationHold On To Your Dreams
Hold On To Your Dreams Dr. Michael Kettel Dr. Sandy Chuan 1. THE BASICS OF IVF & EMBRYO DEVELOPMENT 2. IVF ADD-ONS - MYTH VS. SCIENCE IN VITRO FERTILIZATION 1. Ovarian Stimulation 2. Egg Retrieval 3. Create
More informationArticle Preimplantation genetic diagnosis of numerical abnormalities for 13 chromosomes
RBMOnline - Vol 6. No 2. 226 231 Reproductive BioMedicine Online; www.rbmonline.com/article/794 on web 28 January 2003 Article Preimplantation genetic diagnosis of numerical abnormalities for 13 chromosomes
More informationEmbryo morphology and development are dependent on the chromosomal complement
Embryo morphology and development are dependent on the chromosomal complement M. Cristina Magli, M.Sc., Luca Gianaroli, M.D., Anna Pia Ferraretti, M.D., Ph.D., Michela Lappi, B.Sc., Alessandra Ruberti,
More informationProblem Challenge Need. Solution Innovation Invention
Problem Challenge Need Solution Innovation Invention Tubal Infertility In-vitro Fertilisation Steptoe and Edwards Birth after the reimplantation of a human embryo. Lancet 1978 Louise Brown, 25. Juli 1978
More informationIdentification of embryonic chromosomal abnormality using FISH-based preimplantaion genetic diagnosis
Ye et al. / J Zhejiang Univ SCI 2004 5(10):1249-1254 1249 Journal of Zhejiang University SCIENCE ISSN 1009-3095 http://www.zju.edu.cn/jzus E-mail: jzus@zju.edu.cn Identification of embryonic chromosomal
More informationUNDERSTANDING THE GENETIC HEALTH OF EMBRYOS
UNDERSTANDING THE GENETIC HEALTH OF EMBRYOS What is preimplantation genetic testing for aneuploidy? (an abnormal number of chromosomes; PGT-A) is a testing technique that can help choose embryos that appear
More informationAccuracy of FISH analysis in predicting chromosomal status in patients undergoing preimplantation genetic diagnosis
Accuracy of FISH analysis in predicting chromosomal status in patients undergoing preimplantation genetic diagnosis Catherine M. DeUgarte, M.D., a Man Li, M.D., Ph.D., b Mark Surrey, M.D., c Hal Danzer,
More informationPGS Embryo Screening
PGS Embryo Screening Contents What are chromosomes? 3 Why should I consider chromosome testing of my embryos? 3 Embryo testing using preimplantation genetic screening (PGS) 4 How does PGS and the chromosome
More informationEmbryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities*
FERTILITY AND STERILITY Copyright {j 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Embryo morphology, developmental rates, and maternal age are correlated with
More informationPreimplantation Genetic Testing Where are we going? Genomics Clinical Medicine Symposium Sept 29,2012 Jason Flanagan, MS,CGC
Preimplantation Genetic Testing Where are we going? Genomics Clinical Medicine Symposium Sept 29,2012 Jason Flanagan, MS,CGC Overview Discuss what PGD and PGS are Pt examples What we have learned Where
More informationComparison of development and implantation of human embryos biopsied with two different methods: aspiration and displacement
Comparison of development and implantation of human embryos biopsied with two different methods: aspiration and displacement Wei-Hua Wang, Ph.D., Khalied Kaskar, M.S., Yuhong Ren, M.S., Jimmy Gill, M.D.,
More informationSHOULD WE TEST THE FIRST POLAR BODY OR THE EMBRYO
SHOULD WE TEST THE FIRST POLAR BODY OR THE EMBRYO L. Gianaroli, C.M. Magli, A.P. Ferraretti Reproductive Medicine Unit - Via Mazzini, 12-40138 Bologna sismer@sismer.it WOMEN S REPRODUCTIVE HEALTH IN THE
More informationOriginal Policy Date
MP 2.04.77 Preimplantation Genetic Testing Medical Policy Section OB/Gyn/Reproduction Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to
More informationArticle Pre-embryonic diagnosis for Sandhoff disease
RBMOnline - Vol 12. No 3. 2006 328-333 Reproductive BioMedicine Online; www.rbmonline.com/article/2100 on web 9 January 2006 Article Pre-embryonic diagnosis for Sandhoff disease Dr Anver Kuliev received
More informationArticle Which patients with recurrent implantation failure after IVF benefit from PGD for aneuploidy screening?
RBMOnline - Vol 12. No 3. 2006 334-339 Reproductive BioMedicine Online; www.rbmonline.com/article/1947 on web 25 January 2006 Article Which patients with recurrent implantation failure after IVF benefit
More informationIVF: PAST, PRESENT AND FUTURE
IVF: PAST, PRESENT AND FUTURE Mark Larman Chief Scientific Officer 1 HISTORY OF IVF IVF first achieved with rabbits in 1959 IVF with human gametes - pioneered by Robert Edwards and Patrick Steptoe during
More informationCommittee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler
Committee Paper Committee: Scientific and Clinical Advances Advisory Committee Meeting Date: 12 May 2009 Agenda Item: 4 Paper Number: SCAAC(05/09)01 Paper Title: ICSI guidance Author: Hannah Darby and
More informationReproductive Technology, Genetic Testing, and Gene Therapy
Michael Cummings Chapter 16 Reproductive Technology, Genetic Testing, and Gene Therapy David Reisman University of South Carolina 16.1 Infertility Is a Common Problem In the US, about 13% of all couples
More informationASSISTED REPRODUCTIVE TECHNOLOGIES (ART)
ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) Dr. Herve Lucas, MD, PhD, Biologist, Andrologist Dr. Taher Elbarbary, MD Gynecologist-Obstetrician Geneva Foundation for Medical Education and research Definitions
More informationArticle Influence of spermatogenic profile and meiotic abnormalities on reproductive outcome of infertile patients
RBMOnline - Vol 10. No 6. 2005 735 739 Reproductive BioMedicine Online; www.rbmonline.com/article/1678 on web 13 April 2005 Article Influence of spermatogenic profile and meiotic abnormalities on reproductive
More informationNovel Technologies for Selecting the Best Sperm for IVF and ICSI
Novel Technologies for Selecting the Best Sperm for IVF and ICSI Denny Sakkas, Ph.D. Scientific Director, Boston IVF Waltham, MA, USA Testing The Sperm Population NOW Sperm DNA testing Although we are
More informationFertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.
Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art
More informationRejuvenation of Gamete Cells; Past, Present and Future
Rejuvenation of Gamete Cells; Past, Present and Future Denny Sakkas PhD Scientific Director, Boston IVF Waltham, MA, USA Conflict of Interest I have no conflict of interest related to this presentation.
More informationBlastomere transplantation in human embryos may be a treatment for single gene diseases
FERTILITY AND STERILITY VOL. 81, NO. 4, APRIL 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Blastomere transplantation in
More informationAbstract. Introduction. RBMOnline - Vol 8. No Reproductive BioMedicine Online; on web 19 April 2004
RBMOnline - Vol 8. No 6. 2004 695-700 Reproductive BioMedicine Online; www.rbmonline.com/article/1296 on web 19 April 2004 Article Pronuclear morphology predicts embryo development and chromosome constitution
More informationPatrick Quinn IVF PROTOKOL FOR SINGLE EMBRYO CULTURE
1. With cumulus-free oocytes and embryos up to Day (D) 3, use 275-300 um diameter pipette tips to minimize medium transfer between drops; transfer volume should be < 1 ul. DAY -1 2. At ~ 4.00 pm on the
More informationApplication of OMICS technologies on Gamete and Embryo Selection
Application of OMICS technologies on Gamete and Embryo Selection Denny Sakkas, Ph.D. Scientific Director, Boston IVF Waltham, MA, USA THE FUTURE ROLE OF THE EMBRYOLOGIST WILL FOCUS ON PROVIDING OUR PATIENTS
More informationPreimplantation Genetic Diagnosis (PGD) in Western Australia
Preimplantation Genetic Diagnosis (PGD) in Western Australia Human somatic cells have 46 chromosomes each, made up of the 23 chromosomes provided by the egg and the sperm cell from each parent. Each chromosome
More informationCurrent value of preimplantation genetic aneuploidy screening in IVF
Human Reproduction Update, Vol.13, No.1 pp. 15 25, 2007 Advance Access publication September 7, 2006 doi:10.1093/humupd/dml043 Current value of preimplantation genetic aneuploidy screening in IVF P.Donoso
More informationPATIENT CONSENT FORM Preimplantation Genetic Screening (PGS) 24 Chromosome Aneuploidy and Translocation Screening with acgh
PREIMPLANTATION GENETIC SCREENING FOR ANEUPLOIDY SCREENING INTRODUCTION Preimplantation genetic screening (PGS) is used in conjunction with in-vitro fertilization (IVF) to screen embryos for numerical
More informationPreimplantation genetic diagnosis
Preimplantation genetic diagnosis Borut Peterlin Clinical institute of medical genetics, University Medical Centre Ljubljana Outline of the presentation Primary prevention of genetic diseases Motivation
More informationBlastocyst Morphology Holds Clues Concerning The Chromosomal Status of The Embryo
Original Article Blastocyst Morphology Holds Clues Concerning The Chromosomal Status of The Embryo Rita de Cassia Savio Figueira, M.Sc. 1, Amanda Souza Setti, B.Sc. 1,, Daniela Paes Almeida Ferreira Braga,
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Greco E, Minasi MG, Fiorentino F. Healthy babies after intrauterine
More informationArticle Non-informative results and monosomies in PGD: the importance of a third round of re-hybridization
RBMOnline - Vol 19. No 4. 2009 539 546 Reproductive BioMedicine Online; www.rbmonline.com/article/4053 on web 12 August 2009 Article Non-informative results and monosomies in PGD: the importance of a third
More informationComprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study
ORIGINAL ARTICLES: ASSISTED REPRODUCTION Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study Richard T. Scott
More informationA Stepwise Approach to Embryo Selection and Implantation Success
Precise Genetic Carrier Screening An Overview A Stepwise Approach to Embryo Selection and Implantation Success Put today s most advanced genetic screening technology to work for you and your family s future.
More informationUSA: Livingston, NJ. PGD for infertility. Europe: Barcelona, Spain Oxford, UK Hamburg, Germany. Asia: Kobe, Japan. South America: Lima, Peru
PGD for infertility Santiago Munné USA: Livingston, NJ Europe: Barcelona, Spain Oxford, UK Hamburg, Germany Asia: Kobe, Japan South America: Lima, Peru The majority of embryos with good morphology are
More informationArticles Polar body-based preimplantation diagnosis for X-linked disorders
RBMOnline - Vol 4. No 1. 38 42 Reproductive BioMedicine Online; www.rbmonline.com/article/384 on web 20 November 2001 Articles Polar body-based preimplantation diagnosis for X-linked disorders Dr Yury
More informationThe Impact of ESHRE 2017 on Japanese Fertility Practice
The Impact of ESHRE 2017 on Japanese Fertility Practice This resource is supported by an educational grant from Merck KGaA, Darmstadt, Germany. The GWHA was interested in the opinions of practicing clinicians
More informationDate of birth: / / Date of birth: / /
Name (Female): Partner s name: Date of birth: / / Date of birth: / / IVF Number: Background Information An individual s genetic information is packaged into strings of DNA called chromosomes. Normal human
More informationComprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks?
Comprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks? Embryo 1 Embryo 2 combine samples for a single sequencing chip Barcode 1 CTAAGGTAAC
More informationPre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN
Pre-Implantation Genetic Diagnosis Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Our Clinical Vignette A young couple in the mid-to-late twenties presents to your clinic to discuss having children. The
More informationChromosomes and Human Inheritance. Chapter 11
Chromosomes and Human Inheritance Chapter 11 11.1 Human Chromosomes Human body cells have 23 pairs of homologous chromosomes 22 pairs of autosomes 1 pair of sex chromosomes Autosomes and Sex Chromosomes
More informationComprehensive molecular cytogenetic analysis of the human blastocyst stage
Human Reproduction Vol.23, No.11 pp. 2596 2608, 2008 Advance Access publication on July 29, 2008 doi:10.1093/humrep/den287 Comprehensive molecular cytogenetic analysis of the human blastocyst stage E.
More informationResults of the Virtual Academy of Genetics (VAoGEN) questionnaire on Mosaicism in PGS
Results of the Virtual Academy of Genetics (VAoGEN) questionnaire on Mosaicism in PGS Ariel Weissman, MD IVF Unit, Dep. Ob/Gyn Wolfson Medical Center, Holon Sackler Faculty of Medicine, Tel Aviv University
More informationFertility What do GP s need to know? Richard Fisher Fertility Associates
Fertility 2010 What do GP s need to know? Richard Fisher Fertility Associates New Zealand Source: Max Planck Institute Average age of mother at first birth in New Zealand 35 30 25 20 15 10 5 0 Median Mean
More informationBringing Life to the Living
Bringing Life to the Living ReGenesis Where Life Begins Centre for Assisted Reproduction, Endoscopy and Fetal Medicine Traditionally, infertility is defined as the inability to conceive for more than two
More informationOptimize your success
ANDROLOGY BY ORIGIO Optimize your success by selecting the highest quality sperm QUALITY CONTROL OOCYTE RETRIEVAL ANDROLOGY & IUI FERTILIZATION CULTURE PGD & PGS CRYOPRESERVATION EMBRYO TRANSFER The importance
More informationNew methods for embryo selection: NGS and MitoGrade
New methods for embryo selection: NGS and MitoGrade Santiago Munné, PhD US: Livingston, Los Angeles, Chicago, Portland, Miami / Europe: Barcelona (Spain), Oxford (UK), Hamburg (Germany) / Asia: Kobe (Japan),
More informationReview Chromosome abnormalities and their relationship to morphology and development of human embryos
RBMOnline - Vol 12. No 2. 2006 234-253 Reproductive BioMedicine Online; www.rbmonline.com/article/2051 on web 14 December 2005 Review Chromosome abnormalities and their relationship to morphology and development
More informationArticle Impact of meiotic and mitotic non-disjunction on generation of human embryonic stem cell lines
RBMOn - Vol 18. No 1. 2009 120-126 Reproductive BioMedicine On; www.rbmon.com/article/3656 on web 21 November 2008 Article Impact of meiotic and mitotic non-disjunction on generation of human embryonic
More informationDate of birth: / / Date of birth: / /
Name (Female): Partner s name: Date of birth: / / Date of birth: / / IVF Number: Background Information An individual s genetic information is packaged into strings of DNA called chromosomes. Normal human
More informationZygotes showing a single pronucleus
In vitro development and chromosome constitution of embryos derived from monopronucleated zygotes after intracytoplasmic sperm injection Sílvia Mateo, M.Sc., a Monica Parriego, M.Sc., a Montserrat Boada,
More informationPre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN
Pre-Implantation Genetic Diagnosis Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Our Clinical Vignette A young couple in the mid-to-late twenties presents to your clinic to discuss having children. The
More informationPREIMPLANTATION GENETIC DIAGNOSIS
PREIMPLANTATION GENETIC DIAGNOSIS Peter Braude, Susan Pickering, Frances Flinter and Caroline Mackie Ogilvie Preimplantation genetic diagnosis (PGD) is an evolving technique that provides a practical alternative
More informationThe chromosome pattern of embryos derived from tripronuclear zygotes studied by cytogenetic analysis and fluorescence in situ hybridization*+
FERTILITY AND STERILITY Copyright
More informationNEXCCS. Your guide to aneuploidy screening
NEXCCS Your guide to aneuploidy screening GROWING FAMILIES What is comprehensive chromosome screening? Comprehensive chromosome screening (CCS), also known as preimplantation genetic screening (PGS) or
More informationProf. Antonio Pellicer
Improving outcomes in ART : Time-lapse technology for monitoring COS and blastocyst culture Prof. Antonio Pellicer Instituto Valenciano de Infertilidad (IVI) University of Valencia apellicer@ivi.es www.ivi.es
More informationCongreso Nacional del Laboratorio Clínico 2016
Actualización en Screening Genético Preimplantacional Maria Giulia Minasi Center for Reproductive Medicine European Hospital Rome, Italy Aneuploidy rate can reach 60% in human embryos Aneuploidy increases
More informationDisclosure. Dagan Wells University of Oxford Oxford, United Kingdom
Disclosure Dagan Wells University of Oxford Oxford, United Kingdom Disclosure Declared to be member of the advisory board, board of directors or other similar groups of Illumina Objectives Consider Aneuploidy
More informationBiology of fertility control. Higher Human Biology
Biology of fertility control Higher Human Biology Learning Intention Compare fertile periods in females and males What is infertility? Infertility is the inability of a sexually active, non-contracepting
More informationAssisted Reproductive Technologies
Assisted Reproductive Technologies Textbook pages 224 231 Section 6.3 Summary Before You Read What do you think the phrase test-tube baby refers to? Write your ideas on the lines below. Mark the Text Check
More informationComprehensive chromosome screening and embryo biopsy: advantages and difficulties. Antonio Capalbo, PhD Italy
Comprehensive chromosome screening and embryo biopsy: advantages and difficulties Antonio Capalbo, PhD Italy Disclosure Antonio Capalbo, PhD GEERA, Reproductive medicine centers GEETYX, molecular genetics
More informationPreimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent
Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent PGT analysis is offered to patients that seek to identify a chromosomal abnormality in their embryos prior to initiating
More informationGenetics Review and Reproductive Options in Kennedy Disease
+ Alice Schindler, MS, CGC Genetic Counselor, NIH/NINDS/Neurogenetics Branch Heather Montie, PhD, Assistant Professor Department of Bio-Medical Sciences Philadelphia College of Osteopathic Medicine Annual
More informationSelection of sperm for ICSI: hyaluronan binding
Selection of sperm for ICSI: hyaluronan binding Dave Morroll Director of Embryology Reference Values Volume: 2.0 2.0 1.5 (1.4-1.7) ph: 7.2-7.8 7.2 >7.2 Concn (x10 6 ml): 20 20 15 (12-16) Total count(x10
More informationInfluence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser
Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte
More information24-Feb-15. Learning objectives. Family genetics: The future??? The traditional genetics. Genetics and reproduction in early 2015.
Learning objectives Family genetics: The future??? Peter Illingworth Medical Director IVFAustralia Understand how genetic problems may affect successful conception Consider the possible conditions and
More informationPolar Body Approach to PGD. Anver KULIEV. Reproductive Genetics Institute
Polar Body Approach to PGD Anver KULIEV Reproductive Genetics Institute DISCLOSURE othing to disclose 14 History of Polar Body Approach 14 First proposed in World Health Organization s Document Perspectives
More informationStudy on Several Factors Involved in IVF-ET of Human Beings
Study on Several Factors Involved in IVF-ET of Human Beings Lei X 1, Zhuoran W 1, Bin L 1, Huiming L 1, Hongxiu Z 1, Yajuan Z 1, Yingbo Q 1, Guixue Z 2 1 The First Clinical College of Harbin Medical University,
More informationBlastocentesis: innovation in embryo biopsy
Blastocentesis: innovation in embryo biopsy L. Gianaroli, MC Magli, A. Pomante, AP Ferraretti S.I.S.Me.R. Reproductive Medicine Unit, Bologna, Italy Bologna, 8-11 May 2016 www.iiarg.com www.sismer.it 2013
More informationArticle TESE ICSI in patients with non-mosaic Klinefelter syndrome: a comparative study
RBMOnline - Vol 18. No 6. 2009 756-760 Reproductive BioMedicine Online; www.rbmonline.com/article/3892 on web 17 April 2009 Article TESE ICSI in patients with non-mosaic Klinefelter syndrome: a comparative
More informationNew Innovations and Technologies:
New Innovations and Technologies: How and When in the Fertility Clinic? Prof Darren K Griffin (Biosciences); Prof Sally Sheldon (Law) Centre for Interdisciplinary Studies of Reproduction (CISoR) University
More informationDr Guy Gudex. Gynaecologist and Fertility Specialist Repromed. 9:05-9:30 Advances in Assisted Reproduction What s New?
Dr Guy Gudex Gynaecologist and Fertility Specialist Repromed 9:05-9:30 Advances in Assisted Reproduction What s New? Rotorua GP CME June 2016 Advances in Assisted Reproduction-What s new? Dr Guy Gudex
More informationDNA FRAGMENTATION INDEX (DFI) OF HUMAN SEMEN BY MODIFIED ANILINE BLUE METHOD
DNA FRAGMENTATION INDEX (DFI) OF HUMAN SEMEN BY MODIFIED ANILINE BLUE METHOD *Patil P., Bambulkar S., Ajgaonkar S., Patil R., Patil A. and Nikam V. Department of Anatomy, D Y Patil Medical College and
More informationbioscience explained Vol 4 No 1 Kersti Lundin Unit of Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Kersti Lundin Unit of Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden In vitro fertilisation where are we now? History (b) (a) Fig 1. (a) At oocyte pick-up, the oocytes are aspirated
More informationAdoption and Foster Care
GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.
More informationArticle Paternal gonadal mosaicism detected in a couple with recurrent abortions undergoing PGD: FISH analysis of sperm nuclei proves valuable
RBMOnline - Vol 9. No 2. 2004 225-230 Reproductive BioMedicine Online; www.rbmonline.com/article/1346 on web 18 June 2004 Article Paternal gonadal mosaicism detected in a couple with recurrent abortions
More informationScientifically advanced. Personally accessible.
Scientifically advanced. Personally accessible. EmbryVu. Advanced preimplantation genetic screening that can help you find the path to pregnancy. The power to decide When you are going through treatment
More informationIncrease your chance of IVF Success. PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0)
Increase your chance of IVF Success PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0) What is PGT-A? PGT-A, or Preimplantation Genetic Testing for Aneuploidy (PGS 2.0), is a type of genomic
More information2017 Gap Analysis and Educational Needs Developed by the ASRM Continuing Medical Education Committee
TOPIC GAP(S) IDENTIFIED EDUCATIONAL NEED(S) Access to care Increase insurance coverage Strategies to increase coverage by selfinsureds and insurance companies. Alternatives to insurance coverage including
More informationArticle Negligible interchromosomal effect in embryos of Robertsonian translocation carriers
RBMOnline - Vol 10. No 3. 2005 363-369 Reproductive BioMedicine Online; www.rbmonline.com/article/1630 on web 17 January 2005 Article Negligible interchromosomal effect in embryos of Robertsonian translocation
More informationQuality Control Processes Within the Embryology Laboratory. Klaus E. Wiemer, PhD Laboratory Director
Quality Control Processes Within the Embryology Laboratory Klaus E. Wiemer, PhD Laboratory Director 8/28/2015 1 Introduction Thorough understanding of every process that occurs within the IVF lab is essential
More information